MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.

Our mission is to research, develop, and deliver innovative medicines to improve and extend people’s lives with cancer.